JT001 (VV116) for the Treatment of COVID-19

NCT05582629 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1369

Enrollment

INDUSTRY

Sponsor class

Conditions

Mild to Moderate COVID-19

Interventions

DRUG: JT001
DRUG: Placebo

Sponsor

Shanghai Vinnerna Biosciences Co., Ltd.

Collaborators

[object Object]